Improving Upper Extremity Function and Trunk Stability After Cervical Spinal Cord Injury (SCI)

March 26, 2026 updated by: Candace Tefertiller, Craig Hospital

Improving Upper Extremity Function and Trunk Stability After Cervical Spinal Cord Injury (SCI): A Randomized Controlled Trial of Three Interventions

Ninety-nine individuals meeting the study's inclusion/exclusion criteria will be enrolled in this study. The objective of this study is to evaluate three different therapeutic approaches to synergistically retrain functional movement patterns of the upper extremities in combination with trunk stabilization to promote neurologic and functional recovery after SCI. Each subject will complete 40 sessions of intervention. Subjects will also complete a Baseline Evaluation (week 0), Re-Evaluation (week 4), Post Treatment Evaluation (week 8), and a Follow-Up Evaluation (week 12).

Study Overview

Study Type

Interventional

Enrollment (Estimated)

99

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Englewood, Colorado, United States, 80113
        • Craig Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • History of traumatic SCI
  • Less than 5months post SCI
  • SCI injury level C1-C8
  • SCI categorized as AIS B-D
  • Currently receiving inpatient rehabilitation at Craig Hospital
  • Passive range of motion (ROM) within functional limits at wrists, shoulders, and elbows
  • Demonstrate motor response to electrical stimulation in majority of UE muscle groups below level of injury (tested during screening)
  • No complicating physical or cognitive conditions (as determined by their physician) that would preclude safe use of electrical stimulation
  • Able to complete study as an outpatient if discharged from inpatient rehabilitation before completing 40 sessions of training

Exclusion Criteria:

  • Unstable chronic cardiac or respiratory complaints
  • Current or history of UE contracture or skin pressure injuries that might interfere with intervention
  • Received Botox injections within the last 3 months
  • Pregnant
  • Implanted devices including: pacemaker, spinal cord stimulator, ventriculoperitoneal shunt, deep brain stimulator, or intra-thecal pump.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: FTP Alone
Functional Task Practice Alone - Participants allocated to this group will complete 40 minutes of training focused on improving functional tasks followed by 10 minutes of functional training/carryover in a relevant environment without functional electrical stimulation (FES).
Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins).
Active Comparator: FTP+Con-FES
Functional Task Practice + Conventional Functional Electrical Stimulation - Participants allocated to this group will complete 40 minutes of training focused on improving functional tasks supplemented with conventional parameter (200µs; 40Hz) functional electrical stimulation (FES). followed by 10 minutes of functional training/carryover in a relevant environment.
Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins). Muscle groups will be stimulated at the same time they would be activated naturally in a pre-injury movement pattern utilizing conventional parameter FES.
Active Comparator: FTP+WPHF-FES
Functional Task Practice + Wide Pulse, High Frequency Functional Electrical Stimulation - Participants allocated to this group will complete 40 minutes of training focused on improving functional tasks supplemented with wide pulse, high frequency (1000µs; 100 Hz) functional electrical stimulation (FES) followed by 10 minutes of functional training/carryover in a relevant environment.
Participants will be challenged with training speed, weight, limited therapist support, and context variation (e.g., fine motor activities will vary using objects such as cards, dice, coins). Muscle groups will be stimulated at the same time they would be activated naturally in a pre-injury movement pattern utilizing wide pulse, high frequency parameter FES.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Capabilities of Upper Extremity Test (CUE-T)
Time Frame: Week 0 to Week 12
32 item test, each item scored on a 0-4 point scale with total scores ranging from 0-128.
Week 0 to Week 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Graded Refined Assessment of Strength, Sensibility, and Prehension (GRASSP)
Time Frame: Week 0, Week 8, and Week 12
This multimodal test measures sensorimotor and prehension function in three domains important in describing arm and hand function
Week 0, Week 8, and Week 12
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Sensory Level
Time Frame: Week 0, Week 8, and Week 12
The ISNCSCI involves a detailed examination to determine the sensory level for the right and left sides. The sensory level is the most caudal, intact dermatome. Scores range from 0-2. The higher the score the more intact the dermatome is.
Week 0, Week 8, and Week 12
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Motor Level
Time Frame: Week 0, Week 8, and Week 12
The ISNCSCI involves a detailed examination to determine motor levels for the right and left sides. The motor level is defined as the lowest key muscle function that has a grade of at least a 3, providing key muscle functions represented by segments above that level are judged to be intact. Scores range from 0-5. The higher the score the more intact the muscle is.
Week 0, Week 8, and Week 12
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Neurological Level of Injury
Time Frame: Week 0, Week 8, and Week 12
The ISNCSCI involves a detailed examination to determine the neurological level of injury. The neurological level of injury refers to the most caudal segment of the cord with intact sensation and antigravity muscle function strength, provided that there is normal sensory and motor function rostrally respectively. The neurological level of injury is the most cephalad of the sensory and motor levels.
Week 0, Week 8, and Week 12
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Sacral Sparing
Time Frame: Week 0, Week 8, and Week 12
The ISNCSCI involves a detailed examination to determine whether a spinal cord injury is complete or incomplete. If an injury is considered complete there is an absence of voluntary anal contraction, absent sensory scores of S4-5, and absence of deep anal pressure.
Week 0, Week 8, and Week 12
International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Impairment Grade
Time Frame: Week 0, Week 8, and Week 12
The ISNCSCI involves a detailed examination to determine a spinal cord injury's grade according to the American Spinal Injury Association. Score ranges from A-E. ASIA classification A means spinal injury is considered complete with no sensory or motor function preserved in sacral segments. On the opposite end of the scale an ASIA classification E means 'normal'.
Week 0, Week 8, and Week 12
Pinch Force
Time Frame: Week 0, Week 8, and Week 12
Pinch force will be measured by the Commander Echo Console with the JTech Pinch Dynamometer to quantify finger strength.
Week 0, Week 8, and Week 12
Grasp Force
Time Frame: Week 0, Week 8, and Week 12
Grasp force will be measured by the Commander Echo Console with the JTech Hand Dynamometer to quantify grasp strength.
Week 0, Week 8, and Week 12
Modified Functional Reach (MFR)
Time Frame: Week 0, Week 8, and Week 12
The MFR will be used to measure dynamic trunk stability
Week 0, Week 8, and Week 12
Global Rating of Change (GRC)
Time Frame: Week 0, Week 8, and Week 12
The Global Rating of Change scale assesses perceived change from an intervention. 9 point Likert scale. Higher positive score reflects great improvement
Week 0, Week 8, and Week 12
NeuroRecovery Scale (NRS)
Time Frame: Week 0 and Week 4
The full NRS comprises of 16items. For the purpose of this upper extremity interventional study, only six items will be used that represent a variety of functional upper extremity movement patterns required for ADL management. These scores will be used to guide treatment across all 3 groups. Scores range from 1A-4C. Higher scores reflect greater recovery of spinal cord injury.
Week 0 and Week 4
Demographic Information
Time Frame: Week 0
Demographic information will include: age, sex, race/ethnic background, pre-injury education, employment status, marital status, and living situation.
Week 0
Injury Information
Time Frame: Week 0
Injury information will include: date of injury, cause of injury, baseline AIS classification, and injury level.
Week 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 23, 2022

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

June 1, 2027

Study Registration Dates

First Submitted

December 28, 2021

First Submitted That Met QC Criteria

January 12, 2022

First Posted (Actual)

January 13, 2022

Study Record Updates

Last Update Posted (Actual)

March 30, 2026

Last Update Submitted That Met QC Criteria

March 26, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Spinal Cord Injury

Clinical Trials on FTP Alone

Subscribe